Reproducible and reliable microarray results through quality control: good laboratory proficiency and appropriate data analysis practices are essential

This publication has 46 references indexed in Scilit:

• An integrated bioinformatics infrastructure essential for advancing pharmacogenomics and personalized medicine in the context of the FDA's Critical Path Initiative
  Drug Discovery Today: Technologies, 2007
• Impact of microarray data quality on genomic data submissions to the FDA
  Nature Biotechnology, 2006
• Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer
  Proceedings of the National Academy of Sciences, 2006
• Microarray data analysis: from disarray to consolidation and consensus
  Nature Reviews Genetics, 2006
• FDA pharmacogenomics guidance sends clear message to industry
  Nature Reviews Drug Discovery, 2005
• An array of problems
  Nature Reviews Drug Discovery, 2005
• Microarrays and molecular research: noise discovery?
  The Lancet, 2005
• Prediction of cancer outcome with microarrays: a multiple random validation strategy
  The Lancet, 2005
• Getting the Noise Out of Gene Arrays
  2004
• Evaluation of gene expression measurements from commercial microarray platforms
  Nucleic Acids Research, 2003